Clinical Trials Directory

Trials / Terminated

TerminatedNCT00131482

A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist

A Double-blind, Randomized, Placebo-controlled Phase 2b Study to Establish the Effective Dose Range and to Evaluate the Safety of Chrysalin in Adult Subjects With a Fractured Distal Radius

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
274 (actual)
Sponsor
Capstone Therapeutics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety of Chrysalin, also known as TP508, and to determine the effectiveness of four doses of Chrysalin for treating broken wrists in adults.

Detailed description

There is a medical need for a product that is safe and can accelerate the rate of bone healing, leading to a reduction in immobilization time. Chrysalin, also known as TP508, is a synthetic peptide (protein) that is an exact copy of part of the human protein thrombin, which is a protein that occurs naturally in the body. Chrysalin can be used to mimic part of the thrombin response after injury without stimulating any of the events associated with blood clotting, and can therefore accelerate the normal process of healing.

Conditions

Interventions

TypeNameDescription
DRUGChrysalinPatients were treated with a single percutaneous injection of Chrysalin 3 micrograms at the fracture site at the time of surgery.
DRUGChrysalinPatients were treated with a single percutaneous administration of Chrysalin 1 microgram at the fracture site at the time of surgery.
DRUGChrysalinPatients were treated with a single percutaneous administration of Chrysalin 10 micrograms at the fracture site at the time of surgery.
DRUGChrysalinPatients were treated with a single percutaneous administration of Chrysalin 30 micrograms at the fracture site at the time of surgery.
DRUGPlaceboPatients were treated with a single percutaneous administration of placebo at the fracture site at the time of surgery.

Timeline

Start date
2004-11-01
Primary completion
2007-03-01
Completion
2007-03-01
First posted
2005-08-18
Last updated
2010-08-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00131482. Inclusion in this directory is not an endorsement.